We have significant opportunities to make step-level advances in supply chain efficiency and patient safety goals by leveraging the many new regulations in the areas of UDI, Pharma Serialization, and Product Traceability.
SANTA BARBARA, CALIFORNIA (PRWEB) July 16, 2014
USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Grant Hodgkins, Vice President of the company’s Commercial Solutions and Services, is a member of the GS1 Healthcare Leadership Team.
Hodgkins was elected to the influential healthcare industry leadership team in early July. The team develops and maintains the GS1 Healthcare strategy for successful development and implementation of global standards. The group of industry leaders also helps develop the strategy to carry the GS1 standards message to government agencies that regulate the healthcare industry.
“I am excited to be working on the leadership team during this critical phase of implementation and adoption activities,” said Hodgkins. “As the team approaches its tenth anniversary, we have significant opportunities to make step-level advances in supply chain efficiency and patient safety goals by leveraging the many new regulations in the areas of UDI, Pharma Serialization, and Product Traceability.”
Hodgkins assists USDM Life Sciences clients with Pharmaceutical Track and Trace and a variety of other life sciences enterprise solutions. Hodgkins has three decades of experience in the life sciences industry designing, implementing and managing complex global programs and operations.
About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 14 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit http://www.usdm.com.